• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用双功能螯合剂对异硫氰酸根苯甲基-去铁胺进行锆-89 标记,用于单克隆抗体的放射性核素标记及正电子发射断层扫描成像。

Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine.

机构信息

Department of Otolaryngology, VU University Medical Center, Amsterdam, The Netherlands.

出版信息

Nat Protoc. 2010 Apr;5(4):739-43. doi: 10.1038/nprot.2010.13. Epub 2010 Mar 25.

DOI:10.1038/nprot.2010.13
PMID:20360768
Abstract

The positron emitter zirconium-89 ((89)Zr) has very attractive properties for positron emission tomography (PET) imaging of intact monoclonal antibodies (mAbs) using immuno-PET. This protocol describes the step-by-step procedure for the facile radiolabeling of mAbs or other proteins with (89)Zr using p-isothiocyanatobenzyl-desferrioxamine (Df-Bz-NCS). First, Df-Bz-NCS is coupled to the lysine-NH(2) groups of a mAb at pH 9.0 (pre-modification), followed by purification using gel filtration. Next, the pre-modified mAb is labeled at room temperature by the addition of [(89)Zr]Zr-oxalic acid solution followed by purification using gel filtration. The entire process of pre-modification, radiolabeling and purification steps will take about 2.5 h.

摘要

正电子发射体锆-89((89)Zr) 具有非常吸引人的特性,可用于使用免疫 PET 对完整的单克隆抗体(mAb) 进行正电子发射断层扫描 (PET) 成像。本方案描述了使用对异硫氰酸苯甲基-去铁胺 (Df-Bz-NCS) 轻松对 mAb 或其他蛋白质进行 (89)Zr 放射性标记的逐步程序。首先,在 pH 9.0 下将 Df-Bz-NCS 偶联到 mAb 的赖氨酸-NH(2)基团上(预修饰),然后通过凝胶过滤进行纯化。接下来,通过添加 [(89)Zr]Zr-草酸溶液,在室温下对预修饰的 mAb 进行标记,然后通过凝胶过滤进行纯化。预修饰、放射性标记和纯化步骤的整个过程大约需要 2.5 小时。

相似文献

1
Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine.使用双功能螯合剂对异硫氰酸根苯甲基-去铁胺进行锆-89 标记,用于单克隆抗体的放射性核素标记及正电子发射断层扫描成像。
Nat Protoc. 2010 Apr;5(4):739-43. doi: 10.1038/nprot.2010.13. Epub 2010 Mar 25.
2
p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging.对异硫氰酸根苯甲基去铁胺:一种新型双功能螯合剂,用于方便地用 89Zr 标记单克隆抗体进行免疫 PET 成像。
Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):250-9. doi: 10.1007/s00259-009-1263-1. Epub 2009 Sep 18.
3
Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET.通过一种新型双功能去铁胺螯合物,轻松标记抗表皮生长因子受体纳米抗体用于免疫 PET。
Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):753-63. doi: 10.1007/s00259-010-1700-1. Epub 2011 Jan 6.
4
89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.89Zr免疫正电子发射断层显像:89Zr标记单克隆抗体的综合制备程序
J Nucl Med. 2003 Aug;44(8):1271-81.
5
Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.用于荷瘤裸鼠体内90Y标记单克隆抗体初步探查的定量89Zr免疫正电子发射断层扫描
J Nucl Med. 2003 Oct;44(10):1663-70.
6
Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for Zr-immuno-PET.用于锆免疫正电子发射断层显像的八齿双功能螯合剂DFO*-pPhe-NCS与临床使用的六齿双功能螯合剂DFO-pPhe-NCS的比较。
Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):286-295. doi: 10.1007/s00259-016-3499-x. Epub 2016 Aug 30.
7
Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105.采用 89Zr-Df-TRC105 进行 CD105 表达的正电子发射断层成像。
Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):138-48. doi: 10.1007/s00259-011-1930-x. Epub 2011 Sep 10.
8
Development of a novel long-lived immunoPET tracer for monitoring lymphoma therapy in a humanized transgenic mouse model.开发一种新型的长寿命免疫 PET 示踪剂,用于监测人源化转基因小鼠模型中的淋巴瘤治疗。
Bioconjug Chem. 2012 Jun 20;23(6):1221-9. doi: 10.1021/bc300039r. Epub 2012 Jun 11.
9
(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.(89)锆作为一种正电子发射断层扫描(PET)替代放射性同位素,用于在与内化抗体西妥昔单抗偶联后,在荷瘤裸鼠中探寻治疗性放射性金属(90)钇和(177)镥的生物分布。
J Nucl Med. 2005 Nov;46(11):1898-906.
10
Improving Routine Zr-Immuno-PET Applications: Mild Iron Removal Can Favor the Use of Fe-DFO-N-suc-TFP Ester Over p-NCS-Bz-DFO.改进常规 Zr-免疫 PET 应用:轻度铁去除有利于使用 Fe-DFO-N-suc-TFP 酯而非 p-NCS-Bz-DFO。
J Labelled Comp Radiopharm. 2024 Jun 30;67(8):280-287. doi: 10.1002/jlcr.4097. Epub 2024 May 14.

引用本文的文献

1
Delivery of monoclonal antibodies to the brain: the impact of nanocarrier structure.单克隆抗体向脑部的递送:纳米载体结构的影响。
Drug Deliv Transl Res. 2025 Sep 2. doi: 10.1007/s13346-025-01957-y.
2
LAMP1 as a Target for PET Imaging in Adenocarcinoma Xenograft Models.LAMP1作为腺癌异种移植模型中PET成像的靶点
Pharmaceuticals (Basel). 2025 Jul 27;18(8):1122. doi: 10.3390/ph18081122.
3
New tactics in the design of theranostic radiotracers.治疗诊断放射性示踪剂设计中的新策略。

本文引用的文献

1
Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients.用于头颈癌患者免疫正电子发射断层显像的89Zr标记嵌合单克隆抗体U36的辐射剂量测定
J Nucl Med. 2009 Nov;50(11):1828-36. doi: 10.2967/jnumed.109.065862. Epub 2009 Oct 16.
2
p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging.对异硫氰酸根苯甲基去铁胺:一种新型双功能螯合剂,用于方便地用 89Zr 标记单克隆抗体进行免疫 PET 成像。
Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):250-9. doi: 10.1007/s00259-009-1263-1. Epub 2009 Sep 18.
3
Npj Imaging. 2024 Aug 2;2(1):23. doi: 10.1038/s44303-024-00027-1.
4
MIB guides: [Zr]Zr-DFO-trastuzumab and [Cu]Cu-NOTA-Trastuzumab for Preclinical Cancer Imaging.MIB指南:用于临床前癌症成像的[锆]锆-DFO-曲妥珠单抗和[铜]铜-NOTA-曲妥珠单抗
Mol Imaging Biol. 2025 Jun 26. doi: 10.1007/s11307-025-02022-3.
5
Development of a toxin-selective immunotracer for in vivo detection of Clostridioides difficile infection by immunoPET.开发一种毒素选择性免疫示踪剂,用于通过免疫正电子发射断层扫描在体内检测艰难梭菌感染。
EJNMMI Radiopharm Chem. 2025 Jun 13;10(1):30. doi: 10.1186/s41181-025-00350-x.
6
Detection of immune-mediated tumour cell death in vivo using Zirconium-89-labeled APOMAB®.使用锆-89标记的APOMAB®在体内检测免疫介导的肿瘤细胞死亡。
J Transl Med. 2025 Jun 12;23(1):651. doi: 10.1186/s12967-025-06684-z.
7
Phospholipid Scramblases TMEM16F and Xkr8 regulate distinct features of Phosphatidylserine (PS) externalization and immune regulation in the tumor microenvironment to regulate tumor growth.磷脂翻转酶TMEM16F和Xkr8调节肿瘤微环境中磷脂酰丝氨酸(PS)外化和免疫调节的不同特征,以调节肿瘤生长。
bioRxiv. 2025 Apr 18:2025.04.17.649445. doi: 10.1101/2025.04.17.649445.
8
PET Imaging Expedites Detection of Aberration in the Humanization of an Annexin A1 Targeting Antibody.正电子发射断层扫描(PET)成像加速了膜联蛋白A1靶向抗体人源化过程中异常情况的检测。
Pharmaceuticals (Basel). 2025 Feb 21;18(3):295. doi: 10.3390/ph18030295.
9
Whole-body visualization of SARS-CoV-2 biodistribution in vivo by immunoPET imaging in non-human primates.通过免疫正电子发射断层扫描成像在非人灵长类动物体内对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)生物分布进行全身可视化。
Nat Commun. 2025 Mar 21;16(1):2816. doi: 10.1038/s41467-025-58173-y.
10
Biodistribution of Zr-Radiolabeled Nanoassemblies for Monoclonal Antibody Delivery Revealed through PET Imaging.通过正电子发射断层扫描成像揭示用于单克隆抗体递送的锆标记纳米组装体的生物分布。
ACS Omega. 2025 Jan 28;10(5):4763-4773. doi: 10.1021/acsomega.4c09823. eCollection 2025 Feb 11.
Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging.
用于HER2/neu免疫正电子发射断层显像的临床级89Zr-曲妥珠单抗的研发与特性研究
J Nucl Med. 2009 Jun;50(6):974-81. doi: 10.2967/jnumed.108.060392. Epub 2009 May 14.
4
Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges.用寿命更长的正电子放射性核素进行放射免疫成像:潜力与挑战。
Bioconjug Chem. 2009 May 20;20(5):825-41. doi: 10.1021/bc800299f.
5
Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET.通过正电子发射断层扫描(PET)评估的体内表皮生长因子受体(EGFR)表达与89Zr标记的西妥昔单抗摄取之间的差异。
J Nucl Med. 2009 Jan;50(1):123-31. doi: 10.2967/jnumed.108.054312. Epub 2008 Dec 17.
6
Antibodies and antimatter: the resurgence of immuno-PET.抗体与反物质:免疫正电子发射断层扫描的复兴
J Nucl Med. 2009 Jan;50(1):2-5. doi: 10.2967/jnumed.108.056887. Epub 2008 Dec 17.
7
Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology.通过白蛋白结合改善抗表皮生长因子受体纳米抗体的肿瘤靶向性:利用模块化纳米抗体技术
Mol Cancer Ther. 2008 Aug;7(8):2288-97. doi: 10.1158/1535-7163.MCT-07-2384.
8
Immuno-PET: a navigator in monoclonal antibody development and applications.免疫正电子发射断层显像:单克隆抗体研发与应用的导航工具
Oncologist. 2007 Dec;12(12):1379-89. doi: 10.1634/theoncologist.12-12-1379.
9
In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.使用放射性标记的贝伐单抗对人卵巢肿瘤异种移植模型进行体内血管内皮生长因子(VEGF)成像。
J Nucl Med. 2007 Aug;48(8):1313-9. doi: 10.2967/jnumed.107.041301. Epub 2007 Jul 13.
10
Development trends for monoclonal antibody cancer therapeutics.单克隆抗体癌症治疗药物的发展趋势。
Nat Rev Drug Discov. 2007 May;6(5):349-56. doi: 10.1038/nrd2241.